COMMUNIQUÉS West-GlobeNewswire

Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation
19/07/2024
MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Inspire Medical Systems, Inc. annonce l’approbation du marquage CE qui atteste de la compatibilité de ses appareils avec les examens IRM corps entier et de leur conformité aux exigences du règlement de l’Union européenne sur les dispositifs médicaux
19/07/2024
MINNEAPOLIS, 19 juill. 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE : INSP) (Inspire), entreprise de technologies médicales qui s’attache au développement et à la commercialisation de solutions [...]
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
19/07/2024
MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Inspire Medical Systems, Inc. annonce l’approbation du marquage CE qui atteste de la conformité de la thérapie Inspire aux exigences du règlement de l’Union européenne sur les dispositifs médicaux
19/07/2024
MINNEAPOLIS, 19 juill. 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE : INSP) (Inspire), entreprise de technologies médicales qui s’attache au développement et à la commercialisation de solutions [...]
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
19/07/2024
Exercise of Procurement Option under Current Contract Reflects Continuing Action to Enhance Orthopoxvirus Preparedness NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a [...]
Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product
19/07/2024
Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
SweetWater Brewing Launches New Rowdy Peach IPA in Collaboration With Atlanta United FC
19/07/2024
As Atlanta United’s Official Craft Beer Partner, SweetWater’s New Brew Celebrates the Rowdiest Fans in MLS ATLANTA, July 19, 2024 (GLOBE NEWSWIRE) -- Calling all 17s 1 ! SweetWater Brewing Company (“SweetWater Brewing” [...]
Augmedix to Join Forces with Commure
19/07/2024
Combination to Strengthen Ability to Deliver Frontier Ambient AI Solutions; Augmedix Stockholders to Receive $2.35 Per Share in All-Cash Acquisition by Commure SAN FRANCISCO, July 19, 2024 (GLOBE NEWSWIRE) -- Augmedix, [...]
Nicox announces attendance at upcoming conferences
19/07/2024
Press Release Nicox announces attendance at upcoming conferences July 19 th , 2024 – release at 7:30 am CET Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology [...]
Nicox : Participation aux prochaines conférences
19/07/2024
Communiqué de presse Nicox : Participation aux prochaines conférences 19 juillet 2024 – publication at 7H30 CET Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une [...]
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
19/07/2024
SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients [...]
Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease
18/07/2024
- Independent committee confirms FALCON study is powered for potential success with both alternative endpoints passing futility- -Committee confirms strong safety profile of KL1333- - Abliva to host conference call and [...]
Appili Therapeutics Announces Second Amendment to Arrangement Agreement
18/07/2024
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, July 18, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ [...]
Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation
18/07/2024
HUNTSVILLE, AL, July 18, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug delivery technology, [...]
Treace to Report Second Quarter 2024 Financial Results on August 6, 2024
18/07/2024
PONTE VEDRA, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
18/07/2024
TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free [...]
Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir
18/07/2024
ST. LOUIS, July 18, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced the appointment of Nachum “Homi” Shamir to its [...]
LifeStance to Host Second Quarter 2024 Earnings Conference Call on August 8, 2024
18/07/2024
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, will issue its second quarter 2024 earnings [...]
Codexis to Report Second Quarter 2024 Financial Results on August 8
18/07/2024
REDWOOD CITY, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the second quarter of 2024 on [...]

Pages